Journal Article

Comparison between first and second wave among critically ill COVID-19 patients admitted to a French ICU: no prognostic improvement during the second wave?

Pajot, Olivier, Contou, Damien, Fraissé, Megan, Tirolien, Jo-Anna, Mentec, Hervé, Plantefève, Gaëtan

2021

Overview

Availability of data and materials The dataset used and analyzed for the current study is available from the corresponding author on reasonable request. Effect of hydrocortisone on 21-day mortality or respiratory support among critically ill patients with COVID-19: a randomized clinical trial. Ethics declarations Ethics approval and consent to participate This study was conducted in accordance with the amended Declaration of Helsinki and was approved by the Institutional Review Board (CE 2020-85) of the French Intensive Care Society on the 27th of November 2020. Rights and permissions Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made.

• Publisher: BioMed Central,BioMed Central Ltd,Springer Nature B.V,BMC
• Subject: Aged / Care and treatment / Coronaviruses / Corticoids / COVID-19 / COVID-19 - epidemiology / COVID-19 - therapy / Critical care / Critical Care Medicine / Critical Illness / Critically ill / Delirium / Drug dosages / Emergency Medicine / Epidemics / Female / France / France - epidemiology / Hospitalization / Humans / ICU / Intensive / Intensive care / Intensive Care Units / Intubation / Male / Medicine / Medicine & Public Health / Middle Aged / Mortality / Patient outcomes / Prognosis / Research Letter / Respiratory insufficiency / SARS-CoV-2 / Severe acute respiratory syndrome coronavirus 2 / Statistics / Survival analysis / Thrombosis / Ventilators